Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

A reprise for collaborative financing in biotech

Nature Biotechnology volume 24, pages 873–874 (2006)Cite this article

Collaborative development financing could offer a more objective validation than a standard licensing deals because selection is based on the intrinsic value of the compounds, rather than strategic considerations that often sway a big pharma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Lone Tree, Colorado

    John Ransom

Authors
  1. John Ransom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ransom, J. A reprise for collaborative financing in biotech. Nat Biotechnol 24, 873–874 (2006). https://doi.org/10.1038/nbt0806-873

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0806-873

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing